Moreover, aberrations in PI3K/Akt and MAPK signaling pathways can cause a broad range of diseases, such as metabolic diseases, neurodegenerative diseases, blood diseases and various cancers [52,53,54,55]. Here, AKT1 is linked to metabolic disease.